Skip to main content

Market Overview

Revolution Medicines Raises $260.9 Million In Upsized Offering

  • Revolution Medicines Inc (NASDAQ: RVMD) has priced its upsized underwritten public offering of around 5.8 million common shares at $45 per share, equivalent to gross proceeds of $260.9 million. Previously, the company had offered to sell 4 million shares.
  • Underwriters have an option to purchase up to an additional 869.5 thousand shares, compared to 600 thousand shares announced earlier.
  • RVMD expects the offering to close on February 8.
  • The company intends to use the proceeds to advance specific RAS(ON) inhibitor programs, and the company hopes to advance its RMC-6236 and RMC-6291 into clinical development, as well as make forward progress on its RAS companion inhibitor programs, as well as capital expenditures and operating costs.
  • Have a look at the details here.
  • Price Action: RVMD shares are up marginally by 0.56% at $46.97 in the pre-market session on the last check Thursday.

Related Articles (RVMD)

View Comments and Join the Discussion!

Posted-In: Biotech News Offerings General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at